Season 2 · Episode 1310
S2 Ep1310: NICE Approves New Treatment for Leber Hereditary Optic Neuropathy (LHON)
RNIB Connect · RNIB Connect Radio
August 27, 20258m 57s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
NICE, the National Institute for Health and Care Excellence has recently approved new treatment in England for people living with the eye condition Leber hereditary optic neuropathy (LHON) helped by Researchers at the University of Cambridge.
RNIB Connect Radio’s Toby Davey was joined by Patrick Yu-Wai-Man, Professor of Ophthalmology at the University of Cambridge who was involved in the research into using idebenone to treat Leber hereditary optic neuropathy (LHON) who explains more about the eye condition and how the NICE approved treatment might be appropriate for some people who have LHON.
To find out more about the University of Cambridge research into the new treatment for Leber hereditary optic neuropathy (LHON) do visit the following pages of the University website - https://www.clinical-neuroscience.cam.ac.uk/news/first-ever-mitochondrial-disease-treatment-approved-nhs-england
(Image shows the RNIB Connect Radio logo. On a white background ‘RNIB’ written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio’ is written in black in a smaller font)
RNIB Connect Radio’s Toby Davey was joined by Patrick Yu-Wai-Man, Professor of Ophthalmology at the University of Cambridge who was involved in the research into using idebenone to treat Leber hereditary optic neuropathy (LHON) who explains more about the eye condition and how the NICE approved treatment might be appropriate for some people who have LHON.
To find out more about the University of Cambridge research into the new treatment for Leber hereditary optic neuropathy (LHON) do visit the following pages of the University website - https://www.clinical-neuroscience.cam.ac.uk/news/first-ever-mitochondrial-disease-treatment-approved-nhs-england
(Image shows the RNIB Connect Radio logo. On a white background ‘RNIB’ written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio’ is written in black in a smaller font)